Humanigen Announces Peer-Reviewed Publication in The Journal of Medical Economics Demonstrating the Clinical and Economic Benefits of Lenzilumab
Lenzilumab plus standard of care (SOC), resulted in an estimated cost…
Lenzilumab plus standard of care (SOC), resulted in an estimated cost…

Stay informed with breaking news from Haiti, the Caribbean, the United States, Canada, and around the world. Join thousands of readers who trust CTN every day.
📩 Subscribe to CTN Newsletter
Sign in to your account